Search | OpenScholar

Search results

373 results found

Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes.

Publication: Journal Article

Bajaj, N, RA Hauser, J Seibyl, A Kupsch, M Plotkin, C Chen, and ID Grachev. 2014. “Association Between Hoehn and Yahr, Mini-Mental State Examination, Age, and Clinical Syndrome Predominance and Diagnostic Effectiveness of Ioflupane I 123 Injection (DaTSCAN™) in Subjects With Clinically Uncertain Parkinsonian Syndromes.”. Alzheimers Res Ther.

Which dyskinesia scale best detects treatment response? Mov Disord 2013;28:341-6.

Publication: Journal Article

Goetz, CG, GT Stebbins, KA Chung, RA Hauser, JM Miyasaki, AP Nicholas, W Poewe, et al. 2013. “Which Dyskinesia Scale Best Detects Treatment Response? Mov Disord 2013;28:341-6.”. Mov Disord.

Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls. Neurology 2017;89:1959-1969.

Publication: Journal Article

Mollenhauer, B, CJ Caspell-Garcia, CS Coffey, P Taylor, LM Shaw, JQ Trojanowski, A Singleton, et al. 2017. “Longitudinal CSF Biomarkers in Patients With Early Parkinson Disease and Healthy Controls. Neurology 2017;89:1959-1969.”. Neurology.

Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial. Lancet Neurol 2013;12:346-56.

Publication: Journal Article

Hauser, RA, A Hsu, S Kell, AJ Espay, K Sethi, M Stacy, W Ondo, M O’Connell, and S Gupta. 2013. “Extended-Release Carbidopa-Levodopa (IPX066) Compared With Immediate-Release Carbidopa-Levodopa in Patients With Parkinson’s Disease and Motor Fluctuations: A Phase 3 Randomised, Double-Blind Trial. Lancet Neurol 2013;12:346-56.”. Lancet Neurol.

Pardoprunox as adjunct therapy to levodopa in patients with Parkinson's disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. Parkinsonism Relat Disord 2012;18:370-6.

Publication: Journal Article

Rascol, O, J Bronzova, RA Hauser, AE Lang, C Sampaio, A Theeuwes, and SV Van De Witte. 2012. “Pardoprunox As Adjunct Therapy to Levodopa in Patients With Parkinson’s Disease Experiencing Motor Fluctuations: Results of a Double-Blind, Randomized, Placebo-Controlled, Trial. Parkinsonism Relat Disord 2012;18:370-6.”. Parkinsonism Relat Disord.

Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations.

Publication: Journal Article

Hersh, BP, NL Earl, RA Hauser, and M Stacy. 2010. “Early Treatment Benefits of Ropinirole Prolonged Release in Parkinson’s Disease Patients With Motor Fluctuations.”. Mov Disord.

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.

Publication: Journal Article

Colosimo, C, P Martinez-Martin, G Fabbrini, RA Hauser, M Merello, J Miyasaki, W Poewe, et al. 2010. “Task Force Report on Scales to Assess Dyskinesia in Parkinson’s Disease: Critique and Recommendations.”. Mov Disord.

Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson's disease.

Publication: Journal Article

Rascol, O, P Barone, RA Hauser, Y Mizuno, W Poewe, AH Schapira, L Salin, M Sohr, and C Debieuvre. 2010. “Efficacy, Safety, and Tolerability of Overnight Switching from Immediate- to Once Daily Extended-Release Pramipexole in Early Parkinson’s Disease.”. Mov Disord.

The independent influence of apathy and depression on cognitive functioning in Parkinson's disease

Publication: Journal Article

Butterfield, LC, CR Cimino, LE Oelke, RA Hauser, and J Sanchez-Ramos. 2010. “The Independent Influence of Apathy and Depression on Cognitive Functioning in Parkinson’s Disease”. Neuropsychology.

TEMPO Open-label Study Group. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.

Publication: Journal Article

Hauser, RA, MF Lew, HI Hurtig, WG Ondo, J Wojcieszek, and CJ Fitzer-Attas. 2009. “TEMPO Open-Label Study Group. Long-Term Outcome of Early versus Delayed Rasagiline Treatment in Early Parkinson’s Disease.”. Mov Disord.

Current search

Search found 373 items
(-) 2024
(-) USF Parkinson's Disease and Movement Disorders Center

Sort by

Filter By Post Date

(-) 2024

Filter By Post Type

Filter By Other Sites

(-) USF Parkinson's Disease and Movement Disorders Center

No filters available

Filter By Taxonomy

No filters available